AB0998 Osteoporosis prevalence in post-menopausal patients treated with aromatase inhibitors using bone mineral density values from a spanish population
Loarce-Martos, J., Sifuentes-Giraldo, W.A., Maldonado-Romero, L.V., Ahijón-Lana, M., Velázquez-Arce, C., Martínez-Jañez, N., Vázquez-Díaz, M.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
AB0901 Bone Mineral Density and Morphometric Vertebral Deformities in Postmenopausal Women Receiving Aromatase Inhibitors for Breast Cancer
Maldonado-Romero, L.V., Ahijόn-Lana, M., Velázquez-Arce, C., Sifuentes Giraldo, W.A., Martínez Jañez, N., Vázquez Díaz, M.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain
Ciruelos, E., Vidal, M., Martínez de Dueñas, E., Martínez-Jáñez, N., Fernández, Y., García-Sáenz, J. A., Murillo, L., Carabantes, F., Beliera, A., Fonseca, R., Gavilá, J.
Published in Clinical & translational oncology (01.06.2018)
Published in Clinical & translational oncology (01.06.2018)
Get full text
Journal Article
Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study
Gil-Gil, Miguel J., Bellet, M., Morales, S., Ojeda, B., Manso, L., Mesia, C., Garcia-Martínez, E., Martinez-Jáñez, N., Melé, M., Llombart, A., Pernas, S., Villagrasa, P., Blasco, C., Baselga, J.
Published in Breast cancer research and treatment (01.06.2015)
Published in Breast cancer research and treatment (01.06.2015)
Get full text
Journal Article
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials
Martín, M., Loibl, S., Hyslop, T., De la Haba-Rodríguez, J., Aktas, B., Cirrincione, C.T., Mehta, K., Barry, W.T., Morales, S., Carey, L.A., Garcia-Saenz, J.A., Partridge, A., Martinez-Jañez, N., Hahn, O., Winer, E., Guerrero-Zotano, A., Hudis, C., Casas, M., Rodriguez-Martin, C., Furlanetto, J., Carrasco, E., Dickler, M.N.
Published in European journal of cancer (1990) (01.08.2019)
Published in European journal of cancer (1990) (01.08.2019)
Get full text
Journal Article
P006 Randomized Phase II trial evaluating three anti-diarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06)
González-Santiago, S., Gil-Gil, M., Carrasco, E., Martínez-Jáñez, N., Adamo, B., Antolín, S., Alonso, J.L., Vethencourt, A., Martínez-Vila, C., Galve, E., Rojo, F., Caballero, R., Casas, M., Cortazar, E., McCulloch, L., Vedovato, J.-C., Martín, M.
Published in Breast (Edinburgh) (01.04.2023)
Published in Breast (Edinburgh) (01.04.2023)
Get full text
Journal Article
First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN
Martínez-Jañez, N., Ezquerra, M. Bellet, Manso Sanchez, L. M., Carrasco, F. Henao, Torres, A. Anton, Morales, S., Ortega, P. Tolosa, Gil, V. L. Obadia, Sampedro, T., Conejero, R. Andrés, Calvo-Martinez, L., Galve-Calvo, E., López, R., de la Pena, F. Ayala, Lopez-Tarruella, S., de Araguiz, B. A. Hernando Fernandez, Ruiz, L. Boronat, Cardenas, T. Martos, Chacon, J. I., Antón, F. Moreno
Published in Breast cancer research and treatment (01.07.2024)
Published in Breast cancer research and treatment (01.07.2024)
Get full text
Journal Article
Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
Cortes, J., Perez-Garcia, J., Levy, C., Gómez Pardo, P., Bourgeois, H., Spazzapan, S., Martínez-Jañez, N., Chao, T.-C., Espié, M., Nabholtz, J.M., Gonzàlez Farré, X., Beliakouski, V., Román García, J., Holgado, E., Campone, M.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experience
Pérez Ramírez, S., del Monte-Millán, M., López-Tarruella, S., Martínez Jáñez, N., Márquez-Rodas, I., Lobo Samper, F., Izarzugaza Perón, Y., Rubio Terres, C., Rubio Rodríguez, D., García-Sáenz, J. Á., Moreno Antón, F., Zamora Auñón, P., Arroyo Yustos, M., Lara Álvarez, M. Á., Ciruelos Gil, E. M., Manso Sánchez, L., Echarri González, M. J., Guerra Martínez, J. A., Jara Sánchez, C., Bueno Muiño, C., García Adrián, S., Carrión Galindo, J. R., Valentín Maganto, V., Martín, M.
Published in Clinical & translational oncology (01.05.2020)
Published in Clinical & translational oncology (01.05.2020)
Get full text
Journal Article
Use of bevacizumab as a first-line treatment for metastatic breast cancer
Manso, L, Moreno, F, Márquez, R, Castelo, B, Arcediano, A, Arroyo, M, Ballesteros, A I, Calvo, I, Echarri, M J, Enrech, S, Gómez, A, González Del Val, R, López-Miranda, E, Martín-Angulo, M, Martínez-Jañez, N, Olier, C, Zamora, P
Published in Current oncology (Toronto) (01.04.2015)
Published in Current oncology (Toronto) (01.04.2015)
Get full text
Journal Article
FRI0549 Impact of chemotherapy on bone mineral density in postmenopathic women with breast cancer in treatment with aromatase inhibitors
Loarce-Martos, J, Giraldo, WA Sifuentes, Romero, LV Maldonado, Lana, M Ahijόn, Arce, C Velázquez, Martínez Jañez, N, Vázquez Díaz, M
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
VENTANA (SOLTI-1501): Antiproliferative effect of the addition of oral metronomic vinorelbine to endocrine therapy in luminal/HER2-negative early breast cancer: A window of opportunity trial
Adamo, B., Perez Fidalgo, J.A., Ciruelos, E., Vidal, M., Blanch, S., Lopez, A., Gomez Pardo, P., Murillo, L., Amillano, K., Martínez Jañez, N., Gonzalez, X., Canes, J., Prat, A.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Phase III evaluating the addition of fulvestrant (F) to anastrozol (A) as adjuvant therapy in postmenopausal women with hormone receptor positive HER2 negative (HR+/HER2-) early breast cancer (EBC): Results from the GEICAM/2006-10 study
Ruiz-Borrego, M., Martin Jimenez, M., Ruiz, A., Lluch, A., Ramos, M., Cruz Jurado, J., Baena-Canada, J.M., Cirauqui, B., Rodriguez-Lescure, A., Alba Conejo, E., Martínez Jañez, N., Muñoz, M., Antolin, S., Álvarez López, I., Del Barco, S., Garcia-Estevez, L., Chacon Lopez-Muniz, J.I., Anton Torres, A., Carrasco, E.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Distribution of genomically defined recurrence risk in luminal A and B breast tumors defined by inmunohistochemistry: A retrospective study in Spanish population
Perez Ramirez, S., del Monte-Millán, M., López-Tarruella, S., Márquez-Rodas, I., Jerez, Y., Lobo Samper, F., Izarzugaza Peron, Y., Martínez Jañez, N., García-Saenz, J.A., Moreno Antón, F., Zamora Auñón, P., Arroyo Yustos, M., Lara Álvarez, M.Á., Ciruelos Gil, E.M., Manso Sánchez, L., Echarri González, M.J., Guerra Martínez, J.A., Jara Sánchez, C., Valentín Maganto, V., Martin Jimenez, M.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
SOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (with or without letrozole in ER+) in previously trastuzumab-pretreated, postmenopausal patients with HER2-positive metastatic breast cancer
Villagrasa Gonzalez, P., Prat, A., Oliveira, M., de la Pena, L., Gonzalez, X., Cortes Castan, J., Rios, J., Vázquez, J., Martínez Jañez, N., Perelló Martorell, A., Garau, I., Martinez de Dueñas, E., Morales, S., Melé, M., Bermejo De Las Heras, B., Ciruelos, E.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Tumor-infiltrating lymphocytes (TILs) in HER2-positive (HER2+) early breast cancer treated with neoadjuvant lapatinib and trastuzumab without chemotherapy in the PAMELA Trial
Nuciforo, P., Prat, A., Llombart, A., Fasani, R., Paré, L., Pascual, T., Oliveira, M., Martínez Jañez, N., Bermejo De Las Heras, B., Vidal, M., Pernas Simon, S., López, R., Muñoz, M., Garau, I., Manso, L., Alarcon Company, J., Martinez de Dueñas, E., Villagrasa Gonzalez, P., Cortes Castan, J., Holgado, E.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Abstract OT3-02-07: A phase II study to compare fulvestrant (F) 500mg plus placebo versus (vs) F 500mg plus palbociclib (P) as first line treatment for postmenopausal women with hormone receptor (HR)-positive advanced breast cancer (BC) sensitive to endocrine therapy (ET). “The FLIPPER study” (GEICAM/2014-12)
Moreno, F, Martínez-Jañez, N, Garau, I, Guerra, JA, Alarcón, J, Bermejo, B, Gonzalez-Cortijo, L, Bueno, C, Lao, J, Bezares, S, Rosell, L, Blanch, A, Caballero, R, Carrasco, E, Rojo, F, Martín, M, O'Connor, M, Hernando, A, Albanell, J
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A
Mouron, S, Bueno, M J, Lluch, A, Manso, L, Calvo, I, Cortes, J, Garcia-Saenz, J A, Gil-Gil, M, Martinez-Janez, N, Apala, J V, Caleiras, E, Ximénez-Embún, Pilar, Muñoz, J, Gonzalez-Cortijo, L, Murillo, R, Sánchez-Bayona, R, Cejalvo, J M, Gómez-López, G, Fustero-Torre, C, Sabroso-Lasa, S, Malats, N, Martinez, M, Moreno, A, Megias, D, Malumbres, M, Colomer, R, Quintela-Fandino, M
Published in Nature communications (07.12.2022)
Published in Nature communications (07.12.2022)
Get full text
Journal Article
121P Impact of HER2 low (H2L) expression on prognosis in luminal locally advanced or metastatic breast cancer (BC): A retrospective study
Saavedra Serrano, C., Pérez Mies, B., Gion Cortes, M., Cortes Salgado, A., Fernández Abad, M., Martinez-Jañez, N., Soriano, M., Guerra, E.M., Miranda, E. Lopez
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
1802 Overall survival (OS) from the phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) signaling inhibitor, in AR+ advanced triple-negative breast cancer (aTNBC)
Cortes, J, Crown, J, Awada, A, Schmid, P, Gianni, L, Garcia-Estevez, L, Martinez-Janez, N, Chan, S, Steinberg, J.L, Blaney, M, Tudor, I.C, Uppal, H, Peterson, A, Miller, K, Yardley, D.A, Hudis, C.A, Traina, T.A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article